Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cobomarsen (MRG-106) is an oligonucleotide inhibitor targeting miR-155. This compound effectively suppresses various gene pathways involved in cell survival, such as JAK/STAT, MAPK/ERK, and PI3K/AKT. Cobomarsen is particularly valuable in the study of B-cell lymphoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,130.00 | |
10 mg | Inquiry | $ 1,820.00 |
Description | Cobomarsen (MRG-106) is an oligonucleotide inhibitor targeting miR-155. This compound effectively suppresses various gene pathways involved in cell survival, such as JAK/STAT, MAPK/ERK, and PI3K/AKT. Cobomarsen is particularly valuable in the study of B-cell lymphoma. |
In vitro | Cobomarsen, at a concentration of 10 μM and exposure durations ranging from 48 to 96 hours, effectively hampers cell proliferation and triggers apoptosis in U2932, OCI-LY3, and RCK8 cell lines. Furthermore, a 72-hour exposure to the same concentration markedly enhances the expression of miR-155's four direct targets within cell lines that exhibit miR-155 overexpression. Over a 12-day treatment period, Cobomarsen also significantly deters cellular proliferation and promotes apoptosis in Mycosis Fungoides (MF) and Human T-lymphotropic Virus 1 positive (HTLV-1+) Cutaneous T-cell Lymphoma (CTCL) cells. Additionally, a 7-day application of Cobomarsen, ranging from 10 to 50 μM, diminishes phosphorylation levels of key downstream signaling proteins, namely AKT, ERK1/2, and STAT-3, in primary activated human T cells or MF cell lines. Assays conducted on cell proliferation and apoptosis across U2932, OCI-LY3, and RCK8 cells with a consistent 10 μM concentration of Cobomarsen showcased a dose-dependent reduction in cell phosphorylation and a significant enhancement in late-stage apoptosis across all examined cell lines. |
In vivo | Cobomarsen (1 mg/kg; i.v. on days 0, 2, 4, and 7) significantly reduces tumor growth in five-to-six-week-old female NSG mice implanted with U2932 cell xenografts[2]. This reduction in tumor size is most notable on days 7 and 10, demonstrating the compound's efficacy in this animal model. |
Synonyms | MRG-106, Cobomarsen |
Molecular Weight | N/A |
CAS No. | 1848257-52-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cobomarsen 1848257-52-2 MRG106 MRG-106 MRG 106 inhibitor inhibit